Erythromycin Ethyl Succinate/Sulfisoxazole Acetyl

琥乙红霉素/乙酰磺胺异噁唑

Report date: 2026/03/04 20:01:44

Base Information

Drug NameErythromycin Ethyl Succinate/Sulfisoxazole Acetyl
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitorsDihydropteroate synthase inhibitors
Targets50S ribosomal subunitDihydropteroate synthase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1979/11/29
Country/TerritoryUnited States
CombinationsYes Erythromycin Ethyl SuccinateSulfisoxazole Acetyl
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesRoss Engineering Labs Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoss Engineering Labs Inc
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A